Identification of constitutive and γ-interferon- and interleukin 4- regulated proteins in the human renal carcinoma cell line ACHN

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1137-1143

  Sullivan, Christine M ^a,b   Smith, Diana M ^a,c   Matsui, Neil M ^a,b   Andrews, Lori E ^a   Clauser, Karl R ^a   Chapeaurouge, Alex ^a   Burlingame, Aima L ^a   Epstein, Lois B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN; INTERLEUKIN 4; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN KINASE C INHIBITOR; TROPOMYOSIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; IMMUNOREGULATION; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION;

AMINO ACID SEQUENCE; CARCINOMA, RENAL CELL; CELL DIVISION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG SYNERGISM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; GROWTH INHIBITORS; HEAT-SHOCK PROTEINS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-4; ISOENZYMES; KIDNEY NEOPLASMS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; RECOMBINANT PROTEINS; RIBOSOMAL PROTEINS; SEQUENCE ANALYSIS; SUPEROXIDE DISMUTASE; TROPOMYOSIN; TUMOR CELLS, CULTURED;

EID: 0030935371     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Aggarwal, B. B., and Puri, R. K. Common and uncommon features of cytokines and cytokine receptors: an overview. In: B. B. Aggarwal and R. K. Puri (eds.). Human Cytokines: Their Role in Disease and Therapy, pp. 3-24. Cambridge, MA: Blackwell Science, 1995.
2. Banchereau, J., and Rybak, M. E. Interleukin-4. In: A. Thomson (ed.). The Cytokine Handbook, pp. 99-126. New York: Academic Press, 1994.
3. Farrar, M. A., and Schreiber, R. D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol., 11: 571-611, 1993.
4. Paul, W. E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood, 77: 1859-1870, 1991.
5. Howard, M., Farrar, J., Hilfiker, M., Johnson, B., Takatsu, K., Hamaoka, T., and Paul, W. E. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med., 755: 914-923, 1982.
6. Puri, R. K., and Siegel, J. P. Interleukin-4 and cancer therapy. Cancer Invest., 11: 473-486, 1993.
7. Klouche, M., Kirchner, H., and Hölzel, F. Antiproliferative and recovery effects during treatment of breast and ovarian carcinoma cell cultures with interferon-γ. J. Interferon & Cytokine Res., 15: 285-289, 1995.
8. Yip, I., Pang, X-P., Berg, L., and Hershman, J. M. Antitumor actions of interferon-γ and interleukin-1β on human papillary thyroid carcinoma cell lines. J. Clin. Endocrinol. γ Metab., 80: 1664-1669, 1995.
9. Smith, D. M., and Epstein, L. B. Molecular mechanisms associated with the synergistic antiproliterative action of tumor necrosis factor and interferon-γ on human melanoma cells: characterization of proteins induced or suppressed by cytokine treatment. In: T. Osawa and B. Bonavida (eds.), Tumor Necrosis Factor: Structure-Function Relationship and Clinical Application, pp. 173-182. Basel: S. Karger, 1992.
10. Obiri, N. I., Hillman, G. G., Haas, G. P., Sud, S., and Puri, R. K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth m vitro by interleukin-4. J. Clin. Invest., 91: 88-93, 1993.
11. Hoon, D. S. B., Okun, E., Banez, M., Irie, R. F., and Morton, D. L. Interleukin 4 alone and with γ-interferon or α-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas. Cancer Res., 51: 5687-5693, 1991.
12. Hillman, G. G., Puri, R. K., Kukuruga, M. A., Pontes, J. E., and Haas, G. P. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) on human renal cell carcinoma. Clin. Exp. Immunol., 96: 476-483, 1994.
13. Hall, S. C., Smith, D. M., Masiarz, F. R., Soo, V. W., Tran, H. M., Epstein, L. B., and Burlingame, A. L. Mass spectrometric and Edman sequencing of lipocortin I isolated by two-dimensional SDS/PAGE of human melanoma lysates. Proc. Natl. Acad. Sci. USA, 90: 1927-1931, 1993.
14. Clauser, K. R., Hall, S. C., Smith, D. M., Webb, J. W., Andrews, L. E., Tran, H. M., Epstein, L. B., and Burlingame, A. L. Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. Proc. Natl. Acad. Sci. USA, 92: 5072-5076, 1995.
15. Beresini, M. H., Sugarman, B. J., Shepard, H. M., and Epstein, L. B. Synergistic induction of polypeptides by tumor necrosis factor and interferon-gamma in cells sensitive or resistant to tumor necrosis factor: assessment by computer based analysis of two dimensional gels using the PDQUEST system. Electrophoresis, 11: 232-241, 1990.
16. Smith, D. M., Tran, H. M., and Epstein, L. B. Two-dimensional gel electrophoresis for purification, sequencing, and identification of cytokine-induced proteins in normal and malignant cells. In: F. R. Balkwill (ed.), Cytokines: A Practical Approach, pp. 111-128. New York: IRL at Oxford University Press, 1995.
17. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
18. Rosenfeld, J., Capdevielle, J., Guillemot, J. C., and Ferrara, P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem., 203: 173-179, 1992.
19. Hellman, U., Wernstedt, C., Góñez, J., and Heldin, C-H, Improvement of an "in-gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal. Chem., 224: 451-455, 1995.
20. Matsui, N. M., Smith, D. M., Clauser, K. C., Fichmann, J., Andrews, L. E., Sullivan, C. M., Burlingame, A. L., and Epstein, L. B. Immobilized pH gradient two dimensional electrophoresis and mass spectrometric identification of cytokine-regulated proteins in ME180 cervical carcinoma cells. Electrophoresis. 18: in press, 1997.
21. Medzihradszky, K. F., Adams, G. W., Burlingame, A. L., Bateman, R. H., and Green, M. R. Peptide sequence determination by matrix-assisted laser desorption ionization employing a tandem double focusing magnetic-orthogonal acceleration time-of-flight mass spectrometer. J. Am. Soc. Mass Spectrom., 7: 1-10, 1996.
22. Hunkapiller, M. W., Hewjck, R. M., Dreyer, W. J., and Hood, L. E. High-sensitivity sequencing with a gas-phase sequenator. In: C. H. W. Hirs and S. N. Timasheff (eds.), Methods in Enzymology. pp. 399-413. New York: Academic Press, 1983.
23. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. Basic local alignment search tool. J. Mol. Biol., 275: 403-410, 1990.
24. Ciocca, D. R., Osterreich, S., Chamness, G. C., McGuire, W. L., and Fuqua, S. A. W. Biological and clinical implications of heat shock protein 27000 (Hsp27): a review. J. Natl. Cancer Inst., 85: 1558-1570, 1993.
25. Awasthi, Y. C., Sharma, R., and Singhal, S. S. Human glutathione S-transferases. Int. J. Biochem., 26: 295-308, 1994.
26. Brzoska, P. M., Chen, H., Zhu, Y., Levin, N. A., Disatnik, M-H., Mochly-Rosen, D., Murnane, J. P., and Christman, M. F. The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc. Natl. Acad. Sci. USA, 92: 7824-7828, 1995.
27. Rich, B. E., and Steitz, J. A. Human acidic ribosomal phosphoproteins P0, P1, and P2: analysis of cDNA clones, in vitro synthesis, and assembly. Mol. Cell. Biol., 7: 4065-4074, 1987.
28. Harris, C. A., Derbin, K. S., Hunte-McDonough, B., Krauss, M. R., Chen, K. T., Smith, D. M., and Epstein, L. B. Manganese Superoxide dismutase is induced by IFN-γ in multiple cell types: synergistic induction by IFN-γ and tumor necrosis factor or IL-1. J. Immunol., 147: 149-154, 1991.
29. Cooper, H. L., Bhattacharya, B., Bassin, R. H., and Salomon, D. S. Suppression of synthesis and utilization of tropomyosin in mouse and rat fibroblasts by transforming growth factor α: a pathway in oncogene action. Cancer Res., 47: 4493-4500, 1987.
30. Bhattacharya, B., Prasad, G. L., Valverius, E. M., Salomon, D. S., and Cooper, H. L. Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res., 50: 2105-2112, 1990.
31. Franzén, B., Linder, S., Uryu, K., Alaiya, A. A., Hirano, T., Kalo, H., and Auer, G. Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br. J. Cancer, 73: 909-913, 1996.
32. Prasad, G. L., Fuldner, R. A., and Cooper, H. L. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc. Natl. Acad. Sci. USA, 90: 7039-7043, 1993.
33. Rastinejad, F., Conboy, M. J., Rando, T. A., and Blau, H. M. Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin. Cell, 75: 1107-1117, 1993.
34. Cooper, H. L., Feuerstein, N., Noda, M., and Bassin, R. H. Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol. Cell. Biol., 5: 972-983, 1985.
35. Davis, S., and Watson, J. C. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human α-tropomyosin. Proc. Natl. Acad. Sci. USA, 93: 508-513, 1996.
36. Koromilas, A. E., Roy, S., Barber, G. N., Katze, M. G., and Sonenberg, N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science (Washington DC), 257: 1685-1689, 1992.
37. Meurs, E. F., Galabru, J., Barber, G. N., Katze, M. G., and Hovanessian, A. G. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA, 90: 232-236, 1993.
38. Parsell, D. A., and Lindquist, S. Heat shock proteins and stress tolerance. In: R. I. Morimoto, A. Tissieres, and C. Georgopoulos (eds.), The Biology of Heat Shock Proteins and Molecular Chaperones, pp. 457-494. Plainview, NY: Cold Spring Harbor Laboratory Press, 1994.
39. Arrigo, A-P., and Landry, J. Expression and function of the low-molecular-weight heat shock proteins. In: R. I. Morimoto, A. Tissieres, and C. Georgopoulos (eds.), The Biology of Heat Shock Proteins and Molecular Chaperones, pp. 335-373. Plainview, NY: Cold Spring Harbor Laboratory Press, 1994.
40. Landry, J., Lambert, H., Zhou, M., Lavoie, J. N., Hickey, E., Weber, L. A., and Anderson, C. W. Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J. Biol. Chem., 267: 794-803, 1992.
41. Jungblut, P., Thiede, B., Zimny-Arndt, U., Müller, E-C., Scheler, C., x Wittmann-Liebold, B., and Otto, A. Resolution power of two-dimensional electrophoresis and identification of proteins from gels. Electrophoresis, 17: 839-847, 1996.
42. r 27,000 heat shock protein (hsp27) in in vitro differentiated normal human keratinocytes. Cell Growth & Differ., 5: 777-781, 1994.
43. Knauf, U., Bielka, H., and Gaestel, M. Over-expression of the small heat-shock protein, hsp25, inhibits growth of Erhlich ascites tumor cells. FEBS Lett., 309: 297-302, 1992.
44. Michishita, M., Satoh, M., Yamaguchi, M., Hirayoshi, K., Okuma, M., and Nagata, K. Phosphorylation of the stress protein hsp27 is an early event in murine my elomonocytic leukemic cell differentiation induced by leukemia inhibitory factor/D-factor. Biochem. Biophys. Res. Commun., 776: 979-984, 1991.
45. Olsen, E., Rasmussen, H. H., and Celis, J. E. Identification of proteins that are abnormally regulated in differentiated cultured human keratinocytes. Electrophoresis, 16: 2241-2248, 1995.
46. Oesterreich, S., Weng, C-N., Qiu, M., Hilsenbeck, S. G., Osborne, C. K., and Fuqua, S. A. W. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res., 53: 4443-4448., 1993.
47. Spector, N. L., Samson, W., Ryan, C., Gribben, J., Urba, W., Welch, W. J., and Nadler, L. M. Growth arrest of human B lymphocytes is accompanied by induction of the low molecular weight mammalian heat shock protein (Hsp28). J. Immunol., 148: 1668-1673, 1992.
48. Lavoie, J. N., Lambert, H., Hickey, E., Weber, L. A., and Landry, J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol. Cell. Biol., 15: 505-516, 1995.
49. Mehlen, P., and Arrigo, A-P. The serum-induced phosphorylation of mammalian hsp27 correlates with changes in its intracellular localization and levels of oligomerization. Eur. J. Biochem., 227: 327-334, 1994.
50. r 27,000 heat shock protein. Cancer Res., 57: 5245-5252, 1991.
51. Richards, E. H., Hickey, E., Weber, L., and Masters, J. R. W. Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. Cancer Res., 56: 2446-2451, 1996.
52. Linehan, W. M., Shipley, W. U., and Longo, D. L. Cancer of the kidney and ureter. In: V. T. DeVita, S. Hellman and S. A. Rosenberg (eds.), Cancer: Principles and Practices of Oncology, pp. 979-1007. Philadelphia: J. P. Lippincott Co., 1989.
53. Jakoby, W. B. The glutathione S-transferases: a group of multifunctional detoxification proteins. Adv. Enzymol., 46: 383-414, 1978.
54. Moscow, J. A., Fairchild, C. R., Madden, M. J., Ransom, D. T., Wieand, H. S., O'Brien, E. E., Poplack, D. G., Cossman, J., Myers, C. E., and Cowan, K. H. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res., 49: 1422-1428, 1989.
55. Schecter, R. L., Alaoui-Jamali, M. A., and Batist, G. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis. Biochem. Cell Biol., 70: 349-353, 1992.
56. Ålin, P., Danielson, U. H., and Mannervik, B. 4-hydroxyalk-2-enals are substrates for glutathione transferase. FEBS Lett., 779: 267-270, 1985.
57. Miossec, P., and Banchereau, J. Interleukin 4: a potential antitumor and antiinflammatory agent. In: J. J. Oppenheim, J. L. Rossio, and A. J. H. Gearing (eds.), Clinical Applications of Cytokines: Role in Pathogenesis, Diagnosis and Therapy, pp. 171-176. New York: Oxford University Press, 1993.
58. Balazovich, K. J., McEwen, E. L., Lutzke, M. L., Boxer, L. A., and White, T. Purification of PKC-I, an endogenous protein kinase C inhibitor, and types II and III protein kinase C isoenzymes from human neutrophils. Biochem. J., 284: 399-405, 1992.
59. Goodnight, J., Mischak, H., and Mushinski, J. F. Selective involvement of protein kinase C isozymes in differentiation and neoplastic transformation. Adv. Cancer Res., 64: 159-209, 1994.
60. Olson, E. N., Burgess, R., and Staudinger, J. Protein kinase C as a transducer of nuclear signals. Cell Growth & Differ., 4: 699-705, 1993.
61. Lin, P. S., Ho, K. C., Sung, S. J., and Tsai, S. Cytotoxicity and manganese Superoxide dismutase induction by tumor necrosis factor-α and ionizing radiation inMCF-7 human breast carcinoma cells. Lymphokine & Cytokine Res., 72: 303-308, 1993.
62. Raineri, I., Huang, T-T., Epstein, C. J., and Epstein, L. B. Antisense manganese Superoxide dismutase mRNA inhibits the antiviral action of interferon-& and interferon-α. J. Interferon & Cytokine Res., 76: 61-68, 1996.
63. Epstein, L. B., Smith, D. M., Matsui, N. M., Sullivan, C. M., Raineri, I., Burlingame, A. L., Clauser, K. R., Hall, S. C., and Andrews, L. E. Identification of cytokine-regulated proteins in normal and malignant cells by the combination of 2D-PAGE, mass spectrometry, Edman degradation and immunoblotting and approaches to the analysis of their functional roles. Electrophoresis, 77: 1655-1670, 1996.